Cancer stem cells (CSCs) exhibit several mechanisms of resistance against anticancer drugs that are mainly represented by the expression of ABC transporters and activation of different signaling pathways (e.g., Wnt/β-catenin signaling, Hedgehog, Notch, Akt/PKB). This evidence concerns the gene AKT1 and cancer.